| Retracted and republished: A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy J Cadrin-Tourigny, LP Bosman, A Nozza, W Wang, R Tadros, A Bhonsale, ... European heart journal 40 (23), 1850-1858, 2019 | 336* | 2019 |
| Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: a systematic review and meta-analysis LP Bosman, A Sammani, CA James, J Cadrin-Tourigny, H Calkins, ... Heart rhythm 15 (7), 1097-1107, 2018 | 120 | 2018 |
| Sudden cardiac death prediction in arrhythmogenic right ventricular cardiomyopathy: a multinational collaboration J Cadrin-Tourigny, LP Bosman, W Wang, R Tadros, A Bhonsale, ... Circulation: Arrhythmia and Electrophysiology 14 (1), e008509, 2021 | 109 | 2021 |
| Prediction of ventricular arrhythmia in phospholamban p. Arg14del mutation carriers–reaching the frontiers of individual risk prediction TE Verstraelen, FHM Van Lint, LP Bosman, R De Brouwer, VM Proost, ... European heart journal 42 (29), 2842-2850, 2021 | 86 | 2021 |
| Diagnosing arrhythmogenic right ventricular cardiomyopathy by 2010 Task Force Criteria: clinical performance and simplified practical implementation LP Bosman, J Cadrin-Tourigny, M Bourfiss, M Aliyari Ghasabeh, ... EP Europace 22 (5), 787-796, 2020 | 63 | 2020 |
| Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with … M Linschoten, JAM Kamphuis, A Van Rhenen, LP Bosman, MJ Cramer, ... The Lancet Haematology 7 (4), e295-e308, 2020 | 53 | 2020 |
| Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator P Jordà, LP Bosman, A Gasperetti, A Mazzanti, JB Gourraud, B Davies, ... European heart journal 43 (32), 3041-3052, 2022 | 49 | 2022 |
| Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification LP Bosman, ASJM Te Riele Heart 108 (2), 90-97, 2022 | 48 | 2022 |
| Novel risk calculator performance in athletes with arrhythmogenic right ventricular cardiomyopathy A Gasperetti, AD Russo, M Busana, M Dessanai, F Pizzamiglio, ... Heart rhythm 17 (8), 1251-1259, 2020 | 45 | 2020 |
| Predicting sustained ventricular arrhythmias in dilated cardiomyopathy: a meta‐analysis and systematic review A Sammani, E Kayvanpour, LP Bosman, F Sedaghat‐Hamedani, ... ESC heart failure 7 (4), 1430-1441, 2020 | 37 | 2020 |
| The Netherlands arrhythmogenic cardiomyopathy registry: design and status update LP Bosman, TE Verstraelen, F Van Lint, MGPJ Cox, JA Groeneweg, ... Netherlands Heart Journal 27, 480-486, 2019 | 36 | 2019 |
| Electrocardiographic features differentiating arrhythmogenic right ventricular cardiomyopathy from an athlete’s heart MJ Brosnan, ASJM Te Riele, LP Bosman, ET Hoorntje, MP van den Berg, ... JACC: Clinical Electrophysiology 4 (12), 1613-1625, 2018 | 35 | 2018 |
| Programmed ventricular stimulation as an additional primary prevention risk stratification tool in arrhythmogenic right ventricular cardiomyopathy: a multinational study A Gasperetti, RT Carrick, S Costa, P Compagnucci, LP Bosman, ... Circulation 146 (19), 1434-1443, 2022 | 25 | 2022 |
| Quantitative approach to fragmented QRS in arrhythmogenic cardiomyopathy: from disease towards asymptomatic carriers of pathogenic variants RW Roudijk, LP Bosman, JF van der Heijden, JMT de Bakker, ... Journal of Clinical Medicine 9 (2), 545, 2020 | 20 | 2020 |
| Variant Location Is a Novel Risk Factor for Individuals With Arrhythmogenic Cardiomyopathy Due to a Desmoplakin (DSP) Truncating Variant ET Hoorntje, C Burns, L Marsili, B Corden, VN Parikh, GJ Te Meerman, ... Circulation: Genomic and Precision Medicine 16 (1), e003672, 2023 | 18 | 2023 |
| Longitudinal prediction of ventricular arrhythmic risk in patients with arrhythmogenic right ventricular cardiomyopathy RT Carrick, ASJM Te Riele, A Gasperetti, L Bosman, SA Muller, ... Circulation: Arrhythmia and Electrophysiology 15 (11), e011207, 2022 | 18 | 2022 |
| Blood‐based biomarkers for the prediction of hypertrophic cardiomyopathy prognosis: a systematic review and meta‐analysis M Jansen, S Algül, LP Bosman, M Michels, J van der Velden, RA De Boer, ... ESC heart failure 9 (5), 3418-3434, 2022 | 17 | 2022 |
| Clinical characteristics and follow-up of pediatric-onset arrhythmogenic right ventricular cardiomyopathy RW Roudijk, L Verheul, LP Bosman, M Bourfiss, JMPJ Breur, MG Slieker, ... Clinical Electrophysiology 8 (3), 306-318, 2022 | 16 | 2022 |
| The prevalence of left and right bundle branch block morphology ventricular tachycardia amongst patients with arrhythmogenic cardiomyopathy and sustained ventricular … B Belhassen, M Laredo, RW Roudijk, G Peretto, G Zahavi, ... EP Europace 24 (2), 285-295, 2022 | 16 | 2022 |
| Integrating exercise into personalized ventricular arrhythmia risk prediction in arrhythmogenic right ventricular cardiomyopathy LP Bosman, W Wang, ØH Lie, FHM Van Lint, C Rootwelt-Norberg, ... Circulation: Arrhythmia and Electrophysiology 15 (2), e010221, 2022 | 15 | 2022 |
Folkert AsselbergsCardiologist, Amsterdam University Medical Center, NetherlandsVerified email at amsterdamumc.nl
